PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.\', \'Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.\', \'Biomedical Translation Research Center (BioTReC), Academia Sinica, Taipei, Taiwan.\', \'Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.\', \'Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.\', \'Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan.\', \'Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.\', \'Genomics Research Center, Academia Sinica, Taipei, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/emmm.202012828
?:doi
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 33159417
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all